Novartis Temporarily Powers Down OTC Plant After Form 483

Novartis has temporarily shuttered its Lincoln, Neb., OTC drug plant after being hit with a 13-page Form 483 noting a “pattern of problems” with investigations into foreign tablets in product batches.
Washington Drug Letter